Literature DB >> 26729869

Autoregulatory loop of nuclear corepressor 1 expression controls invasion, tumor growth, and metastasis.

Olaia A Martínez-Iglesias1, Elvira Alonso-Merino1, Sara Gómez-Rey1, Juan Pedro Velasco-Martín2, Rosa Martín Orozco1, Enrique Luengo1, Rosa García Martín3, Inmaculada Ibáñez de Cáceres4, Agustín F Fernández5, Mario F Fraga6, Pilar González-Peramato7, Constantino Varona8, José Palacios8, Javier Regadera2, Ana Aranda9.   

Abstract

Nuclear corepressor 1 (NCoR) associates with nuclear receptors and other transcription factors leading to transcriptional repression. We show here that NCoR depletion enhances cancer cell invasion and increases tumor growth and metastatic potential in nude mice. These changes are related to repressed transcription of genes associated with increased metastasis and poor prognosis in patients. Strikingly, transient NCoR silencing leads to heterochromatinization and stable silencing of the NCoR gene, suggesting that NCoR loss can be propagated, contributing to tumor progression even in the absence of NCoR gene mutations. Down-regulation of the thyroid hormone receptor β1 (TRβ) appears to be associated with cancer onset and progression. We found that expression of TRβ increases NCoR levels and that this induction is essential in mediating inhibition of tumor growth and metastasis by this receptor. Moreover, NCoR is down-regulated in human hepatocarcinomas and in the more aggressive breast cancer tumors, and its expression correlates positively with that of TRβ. These data provide a molecular basis for the anticancer actions of this corepressor and identify NCoR as a potential molecular target for development of novel cancer therapies.

Entities:  

Keywords:  metastasis; nuclear corepressor 1; thyroid hormone receptor; transcription; tumor growth

Mesh:

Substances:

Year:  2016        PMID: 26729869      PMCID: PMC4725484          DOI: 10.1073/pnas.1520469113

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  56 in total

1.  Purification and functional characterization of the human N-CoR complex: the roles of HDAC3, TBL1 and TBLR1.

Authors:  Ho-Geun Yoon; Doug W Chan; Zhi-Qing Huang; Jiwen Li; Joseph D Fondell; Jun Qin; Jiemin Wong
Journal:  EMBO J       Date:  2003-03-17       Impact factor: 11.598

2.  The functional interaction between the paired domain transcription factor Pax8 and Smad3 is involved in transforming growth factor-beta repression of the sodium/iodide symporter gene.

Authors:  Eugenia Costamagna; Bibian García; Pilar Santisteban
Journal:  J Biol Chem       Date:  2003-11-17       Impact factor: 5.157

Review 3.  The role of corepressors in transcriptional regulation by nuclear hormone receptors.

Authors:  Martin L Privalsky
Journal:  Annu Rev Physiol       Date:  2004       Impact factor: 19.318

4.  Local hypothyroidism favors the progression of preneoplastic lesions to hepatocellular carcinoma in rats.

Authors:  Carla Frau; Roberto Loi; Annalisa Petrelli; Andrea Perra; Silvia Menegon; Marta Anna Kowalik; Silvia Pinna; Vera Piera Leoni; Francesca Fornari; Laura Gramantieri; Giovanna Maria Ledda-Columbano; Silvia Giordano; Amedeo Columbano
Journal:  Hepatology       Date:  2014-11-26       Impact factor: 17.425

5.  Insight into hepatocellular carcinogenesis at transcriptome level by comparing gene expression profiles of hepatocellular carcinoma with those of corresponding noncancerous liver.

Authors:  X R Xu; J Huang; Z G Xu; B Z Qian; Z D Zhu; Q Yan; T Cai; X Zhang; H S Xiao; J Qu; F Liu; Q H Huang; Z H Cheng; N G Li; J J Du; W Hu; K T Shen; G Lu; G Fu; M Zhong; S H Xu; W Y Gu; W Huang; X T Zhao; G X Hu; J R Gu; Z Chen; Z G Han
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-18       Impact factor: 11.205

6.  Expression analysis of estrogen receptor alpha coregulators in breast carcinoma: evidence that NCOR1 expression is predictive of the response to tamoxifen.

Authors:  Igor Girault; Florence Lerebours; Samira Amarir; Sengül Tozlu; Michèle Tubiana-Hulin; Rosette Lidereau; Ivan Bièche
Journal:  Clin Cancer Res       Date:  2003-04       Impact factor: 12.531

7.  Methylation of histone H3 lysine 9 creates a binding site for HP1 proteins.

Authors:  M Lachner; D O'Carroll; S Rea; K Mechtler; T Jenuwein
Journal:  Nature       Date:  2001-03-01       Impact factor: 49.962

8.  Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor.

Authors:  A J Hörlein; A M Näär; T Heinzel; J Torchia; B Gloss; R Kurokawa; A Ryan; Y Kamei; M Söderström; C K Glass
Journal:  Nature       Date:  1995-10-05       Impact factor: 49.962

9.  The N-CoR/histone deacetylase 3 complex is required for repression by thyroid hormone receptor.

Authors:  Takahiro Ishizuka; Mitchell A Lazar
Journal:  Mol Cell Biol       Date:  2003-08       Impact factor: 4.272

10.  A corepressor/coactivator exchange complex required for transcriptional activation by nuclear receptors and other regulated transcription factors.

Authors:  Valentina Perissi; Aneel Aggarwal; Christopher K Glass; David W Rose; Michael G Rosenfeld
Journal:  Cell       Date:  2004-02-20       Impact factor: 41.582

View more
  23 in total

1.  Thyroid Hormone Receptor β Inhibits Self-Renewal Capacity of Breast Cancer Stem Cells.

Authors:  Irene López-Mateo; Elvira Alonso-Merino; Cristian Suarez-Cabrera; Jeong Won Park; Sheue-Yann Cheng; Susana Alemany; Jesús M Paramio; Ana Aranda
Journal:  Thyroid       Date:  2019-12-30       Impact factor: 6.568

Review 2.  GC-1: A Thyromimetic With Multiple Therapeutic Applications in Liver Disease.

Authors:  Amedeo Columbano; Grazia Chiellini; Marta Anna Kowalik
Journal:  Gene Expr       Date:  2017-06-13

Review 3.  Paradigms of Dynamic Control of Thyroid Hormone Signaling.

Authors:  Antonio C Bianco; Alexandra Dumitrescu; Balázs Gereben; Miriam O Ribeiro; Tatiana L Fonseca; Gustavo W Fernandes; Barbara M L C Bocco
Journal:  Endocr Rev       Date:  2019-08-01       Impact factor: 19.871

4.  A genome-wide analysis of colorectal cancer in a child with Noonan syndrome.

Authors:  Rahul M Prasad; Rajen J Mody; George Myers; Melisa Mullins; Zaher Naji; James D Geiger
Journal:  Pediatr Blood Cancer       Date:  2018-07-24       Impact factor: 3.167

5.  A novel thyroid hormone receptor isoform, TRβ2-46, promotes SKP2 expression and retinoblastoma cell proliferation.

Authors:  Zhengke Li; Dong-Lai Qi; Hardeep P Singh; Yue Zou; Binghui Shen; David Cobrinik
Journal:  J Biol Chem       Date:  2019-01-14       Impact factor: 5.157

6.  Loss of tyrosine phosphorylation at Y406 abrogates the tumor suppressor functions of the thyroid hormone receptor β.

Authors:  Jeong Won Park; Li Zhao; Mark C Willingham; Sheue-Yann Cheng
Journal:  Mol Carcinog       Date:  2016-06-14       Impact factor: 4.784

7.  Diagnostic significance and potential function of miR-338-5p in hepatocellular carcinoma: A bioinformatics study with microarray and RNA sequencing data.

Authors:  Liang Liang; Li Gao; Xiao-Ping Zou; Meng-Lan Huang; Gang Chen; Jian-Jun Li; Xiao-Yong Cai
Journal:  Mol Med Rep       Date:  2017-11-21       Impact factor: 2.952

8.  Global transcriptomic analysis suggests carbon dioxide as an environmental stressor in spaceflight: A systems biology GeneLab case study.

Authors:  Afshin Beheshti; Egle Cekanaviciute; David J Smith; Sylvain V Costes
Journal:  Sci Rep       Date:  2018-03-08       Impact factor: 4.379

9.  The nuclear corepressor 1 and the thyroid hormone receptor β suppress breast tumor lymphangiogenesis.

Authors:  Olaia Martínez-Iglesias; David Olmeda; Elvira Alonso-Merino; Sara Gómez-Rey; Ana M González-López; Enrique Luengo; María S Soengas; José Palacios; Javier Regadera; Ana Aranda
Journal:  Oncotarget       Date:  2016-11-29

Review 10.  Epigenetic determinants of metastasis.

Authors:  Saroor A Patel; Sakari Vanharanta
Journal:  Mol Oncol       Date:  2016-10-08       Impact factor: 6.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.